Human immunodeficiency virus (HIV) and hepatitis C virus (HCV) in a Northern Alberta population

Canadian Journal of Public Health

Volumn 95, Issue 3, 2004, Pages 188-192

  Bowker, Samantha L ^a   Saskolne, Colin L ^a   Houston, Stan C ^a   Newman, Stephen C ^a   Jhangri, Gian S ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; AGE DISTRIBUTION; ARTICLE; CANADA; COHORT ANALYSIS; COMORBIDITY; CONTROLLED STUDY; DEMOGRAPHY; ETHNIC DIFFERENCE; FEMALE; HEALTH BEHAVIOR; HEPATITIS C; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; INTRAVENOUS DRUG ABUSE; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SEX DIFFERENCE; STATISTICAL ANALYSIS; CROSS-SECTIONAL STUDY; DISEASE TRANSMISSION; RISK FACTOR; SEX RATIO; SUBSTANCE ABUSE;

ADULT; AGE DISTRIBUTION; ALBERTA; CROSS-SECTIONAL STUDIES; FEMALE; HEPATITIS C; HIV INFECTIONS; HUMANS; MALE; PREVALENCE; RISK FACTORS; SEX DISTRIBUTION; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 2942717093     PISSN: 00084263     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03403646     Document Type: Article

References (22)

1. Bureau of HIV/AIDS, STD and TB Update Series, Laboratory Centre for Disease Control. HIV/AIDS Epi update. Available on-line at: www.hc-sc.gc.ca/hpb/lcdc/bah/epi/ estima_e.html, November 2000.
2. Bruneau J, Lamothe F, Franco E, Lachance N, Desy M, Soto J, et al. High rates of HIV infection among injection drug users participating in needle exchange programs in Montreal: Results of a cohort study. Am J Epidemiol 1997;146(12):994-1002.
3. Van der Poel CL, Cuypers HR, Reesink HW. Hepatitis C virus six years on. Lancet 1994;344(8935):1475-79.
4. Boyer N, Marcellin P, Degott C, Degos F, Saimot AG, Erlinger S, et al. Recombinant Interferon-a for chronic hepatitis C in patients positive for antibody to human immunodeficiency virus. J Infect Dis 1992;165(4):723-26.
5. Brettler DB, Alter HJ, Dienstag JL, Forsberg AD, Levine PH. Prevalence of hepatitis C virus anti-body in a cohort of hemophilia patients. Blood 1990;76(1):254-56.
6. Brettler DB, Mannucci PM, Gringeri A, Rasko JE, Forsberg AD, Rumi MG, et al. The low risk of hepatitis C virus transmission among sexual partners of hepatitis C infected haemophiliac males: An international multicenter study. Blood 1992;80(2):540-43.
7. Huet C, Dabis F, Saillour F, Trimoulet P, Morlat P, Rispal P, et al. Multicenter study of intrafamilial transmission of hepatitis C virus in human immunodeficiency virus infection. Gastroenterol Clin Biol 2000;24(6-7):611-17.
8. Zarski JP, Leroy V. Counselling patients with hepatitis C. J Hepatol 1999;31 Suppl 1: 136-40.
9. Zou S, Tepper M, Giulivi A. Current status of hepatitis C in Canada. Can J Public Health 2000;91(Suppl. 1):S1O-S15.
10. Mele A, Tosti ME, Marzolini A, Moiraghi A, Ragni P, Gallo G, et al. Prevention of hepatitis C in Italy: Lessons from surveillance of type-specific acute viral hepatitis. SEIEVA Collaborating Group. J Viral Hepatol 2000;7(1):30-35.
11. Conry-Cantilena C, Van Raden M, Gibble J, Melpolder J, Shakil AO, Viladomiu L, et al. Routes of infection, viremia, and liver disease in blood donors found to have hepatitis C virus infection. N Engl J Med 1996;334(26):1691-96.
12. Alter MJ. Epidemiology of hepatitis C. Hepatology 1997;26(3 Suppl 1):62S-65S.
13. Kaldor JM, Dore GJ, Correll PK. Public health challenges in hepatitis C virus infection. J Gastroenterol Hepatol 2000; 15 Suppl:E83-90.
14. Murphy EL, Bryzman SM, Glynn SA, Ameti DI, Thomson RA, Williams AE, et al. Risk factors for hepatitis C virus infection in United States blood donors. NHLBI Retrovirus Epidemiology Donor Study (REDS). Hepatology 2000;31(3):756-62.
15. Remis R, Hogg R, Krahn MD, et al. Estimating the number of blood transfusion recipients infected by hepatitis C virus in Canada, 1960-85 and 1990-92. Report to Health Canada, June 1998.
16. PPHB Surveillance. Disease Surveillance: Notifiable Diseases On-Line. http://www.hc-sc.gc.ca/pphb-dgspsp/surveillance_e.html September 2000.
17. Strathdee SA, Patrick DM, Currie SL, Cornelisse PG, Rekart ML, Montaner JS, et al. Needle exchange is not enough: Lessons from the Vancouver Injecting Drug Use Study. AIDS 1997;11(8):F59-65.
18. Bowker SL. The pathogenesis of human immunodeficiency virus in a cohort of patients co-infected with hepatitis C virus [thesis]. Edmonton, Alberta: University of Alberta, 2001.
19. Houston S, Rowe B, Mashinter L, Preiksaitis J, Joffe M, Mackey D, et al. Anonymous unlinked seroprevalence of HIV and hepatitis C in two emergency departments - using patient databases to distinguish previously diagnosed cases. XIII International AIDS Conference. Durban, South Africa, July 9-14, 2000. Abstract Number MoPeC2411.
20. Bierhoff E, Fischer HP, Wilisch E, Rockstroh J, Spengler U, Brackmann HH, et al. Liver histopathology in patients with concurrent chronic hepatitis C and HIV infection. Virchows Arch 1997;430(4):271-77.
21. Cribier B, Rey D, Schmitt C, Lang JM, Kim A, Stoll-Keller F. High hepatitis C viraemia and impaired antibody response in patients co-infected with HIV. AIDS 1995;9(10):1131-36.
22. Castro KG, Ward JW, Slutsker L, et al. 1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults. From the National Centre for Infectious Doseases of HIV/AIDS, Centres for Diseases Control and Prevention, Atlanta, GA 1993;17:802-10.